Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>Citi: ALI HEALTH Interim Rev. & NP Beat; Focus on Potential Raising of Results Guidance
Recommend 8 Positive 13 Negative 7 |
||||
|
||||
|
ALI HEALTH (00241.HK)'s interim revenue rose by 17% YoY, while its net profit reached RMB1.266 billion, exceeding expectations by 4% and 13%, respectively, according to a report from Citi. During the period, ALI HEALTH's adjusted net profit grew by 38.7% YoY, while its gross profit margin improved by 30 bps to 25.1%. The report highlighted that ALI HEALTH raised its full-year revenue growth guidance for FY26 to 10-15% in September and increased its adjusted net profit growth guidance to 20-30%. Given the strong adjusted net profit growth recorded during the period, Citi believes the market will focus on whether the company's management will correspondingly lift its results guidance. Citi kept a Buy / High Risk rating on ALI HEALTH, with a target price of HKD8.5. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
